Purpose: The association of central retinal vein occlusion (CRVO) with primary open-angle glaucoma (POAG) or ocular hypertension has been reported, and lowering intraocular pressure (IOP) helps to improve the retinal circulation in eyes with CRVO. However, the clinical features of CRVOs with normal-tension glaucoma (NTG) are not well known. Therefore, we investigated Japanese CRVO patients with NTG. Methods: We retrospectively investigated 234 CRVO patients over 5 years, with follow-ups of more than 12 months, and evaluated the prevalence of glaucoma. Results: Of the 234 CRVO patients, 18 (7.7%) were diagnosed with NTGs (n = 10) or POAGs (n = 8). Seven POAG (87.5%) and 3 NTG (30%) patients had systemic hypertension. At the initial CRVO evaluation, 6 NTGs showed a significantly increased IOP; mean IOP was 13.3 mm Hg before CRVO, 16.2 mm Hg at CRVO, and 13.5 mm Hg at the final visit. Conclusions: The proportion of NTGs with systemic hypertension was low. IOP of NTG patients was significantly elevated at the initial CRVO evaluation, even in the presence of anti-glaucoma drugs.

1.
Kang MH, Balaratnasingam C, Yu PK, Morgan WH, McAllister IL, Cringle SJ, Yu DY: Morphometric characteristics of central retinal artery and vein endothelium in the normal human optic nerve head. Invest Ophthalmol Vis Sci 2011;52:1359-1367.
2.
The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114:545-554.
3.
Sodi A, Giambene B, Marcucci R, Sofi F, Fedi S, Abbate R, Prisco D, Menchini U: Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion. Retina 2011;31:724-729.
4.
Stem MS, Talwar N, Comer GM, Stein JD: A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2013;120:362-370.
5.
David R, Zangwill L, Badarna M, Yassur Y: Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Int J Ophthalmol 1998;197:69-74.
6.
Hayreh SS: Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005;24:493-519.
7.
Chen HF, Chen MC, Lai CC, Yeung L, Wang NK, Chen HS, Ku WC, Wu SC, Chang SH, Chuang LH: Neovascular glaucoma after central retinal vein occlusion in pre-existing glaucoma. BMC Ophthalmol 2014;14:119.
8.
Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA: Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology 1998;105:765-771.
9.
Koizumi H, Ferrara DC, Brue C, Spaide RF: Central retinal vein occlusion case-control study. Am J Ophthalmol 2007;144:858-863.
10.
Beaumont PE, Kang HK: Cup-to-disc ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion. Ophthalmology 2002;109:282-286.
11.
Beaumont PE, Kang HK: Clinical characteristics of retinal venous occlusions occurring at different sites. Br J Ophthalmol 2002;86:572-580.
12.
Wittstrom E, Ponjavic V, Lovestam-Adrian M, Larsson J, Andreasson S: Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Acta Ophthalmol 2010;88:86-90.
13.
Chew EY, Trope GE, Mitchell BJ: Diurnal intraocular pressure in young adults with central retinal vein occlusion. Ophthalmology 1987;94:1545-1549.
14.
Klein BE, Meuer SM, Knudtson MD, Klein R: The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol 2006;141:859-862.
15.
Nuyts RM, Van Diemen HA, Greve EL: Occlusion of the retinal vasculature after trabeculectomy with mitomycin C. Int Ophthalmol 1994;18:167-170.
16.
Dev S, Herndon L, Shields MB: Retinal vein occlusion after trabeculectomy with mitomycin C. Am J Ophthalmol 1996;122:574-575.
17.
Lip PL, Corridan PG: Worsening of an existing hemispheric retinal vein occlusion following further hypotony procedure. Eye 2000;14(Pt 3A):402-404.
18.
Suzuki R, Nakayama M, Satoh N: Three types of retinal bleeding as a complication of hypotony after trabeculectomy. Int J Ophthalmol 1999;213:135-138.
19.
Wu SC: Central retinal vein occlusion after trabeculectomy with mitomycin C. Can J Ophthalmol 2001;36:37-39.
20.
Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y: The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004;111:1641-1648.
21.
Mozaffarieh M, Flammer J: New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharm 2013;13:43-49.
22.
Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP: Senescent changes in cerebrospinal fluid circulatory physiology and their role in the pathogenesis of normal-tension glaucoma. Am J Ophthalmol 2013;156:5-14.e12.
23.
Hayreh SS, Zimmerman MB, Beri M, Podhajsky P: Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology 2004;111:133-141.
24.
Appiah AP, Trempe CL: Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 1989;21:153-155, 157.
25.
Rehak M, Wiedemann P: Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010;8:1886-1894.
26.
Paques M, Brolly A, Benesty J, Lerme N, Koch E, Rossant F, Bloch I, Girmens JF: Venous nicking without arteriovenous contact: the role of the arteriolar microenvironment in arteriovenous nickings. JAMA Ophthalmol 2015;133:947-950.
27.
Scripsema NK, Garcia PM, Bavier RD, Chui TY, Krawitz BD, Mo S, Agemy SA, Xu L, Lin YB, Panarelli JF, Sidoti PA, Tsai JC, Rosen RB: Optical coherence tomography angiography analysis of perfused peripapillary capillaries in primary open-angle glaucoma and normal-tension glaucoma. Invest Ophthalmol Vis Sci 2016;57:611-620.
28.
Li S, Zhang A, Cao W, Sun X: Elevated plasma endothelin-1 levels in normal tension glaucoma and primary open-angle glaucoma: a meta-analysis. J Ophthalmol 2016;2016:2678017.
29.
Flammer J, Konieczka K: Retinal venous pressure: the role of endothelin. EPMA J 2015;6:21.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.